Literature DB >> 9786466

Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?

A P Johnson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9786466     DOI： 10.1093/jac/42.3.289

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options.

Authors:  M J Rybak; R L Akins
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.

Authors:  F C Tenover; J W Biddle; M V Lancaster
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

3.  Isolation and antimicrobial susceptibility pattern of Staphylococcus aureus in patients with surgical site infection at Debre Markos Referral Hospital, Amhara Region, Ethiopia.

Authors:  Amlsha Kahsay; Adane Mihret; Tamrat Abebe; Tebkew Andualem
Journal:  Arch Public Health       Date:  2014-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.